Anti-TNF Agents in Elderly IBD Patients: Cause for Concern?

J Crohns Colitis. 2020 Jul 30;14(7):881-882. doi: 10.1093/ecco-jcc/jjaa025.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adalimumab / therapeutic use*
  • Adult
  • Age Factors
  • Aged
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Infliximab / therapeutic use*
  • Middle Aged
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab